Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2018

01.09.2018 | Retinal Disorders

Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography

verfasst von: Maiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, Kazuaki Kadonosono

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the prognosis and response of neovascular age-related macular degeneration (AMD) to anti-vascular endothelial growth factor (VEGF), according to the components of subretinal hyperreflective material (SHRM) classified using optical coherence tomography angiography (OCTA), is the aim of this study.

Methods

We retrospectively studied 39 eyes of 39 consecutive patients with SHRM associated with exudative AMD, who underwent standard examination and multimodal imaging, including fundus photography, optical coherence tomography (OCT), and OCTA. We classified SHRM into type 2 neovascularization (NV), fibrosis, subretinal hyperreflective exudation (SHE), and hemorrhage using OCTA. If compound SHRM was found, components in the foveal center were considered. All patients except one with fibrosis received anti-VEGF treatment for more than 12 months. The best-corrected visual acuity (BCVA) values measured before treatment and at 3, 6, and 12 months after the first injection were compared according to the components of SHRM.

Results

Using OCTA, 11 eyes with type 2 NV showed abnormal blood flow and 1 eye with fibrosis showed strong surface projection. Both SHE and hemorrhage components showed projection artifact with no intrinsic flow. However, OCTA enabled eyes with SHE (17 eyes) to be distinguished from those with hemorrhage (10 eyes) because hemorrhage showed masking of choriocapillaris flow. Eyes with SHE showed a significant improvement in the mean logMAR BCVA as compared with the value at the baseline, which was sustained throughout the 12-month follow-up period (p < 0.05). In eyes with type 2 NV and hemorrhage, no significant difference in the mean BCVA values was observed at any follow-up time-point (all, p > 0.05).

Conclusion

OCTA was useful to noninvasively distinguish SHRM components. It may be important to consider the components of SHRM to predict the visual acuity in patients with AMD.
Literatur
1.
Zurück zum Zitat Ying GS, Huang J, Maguire MG et al (2013) Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 120:122–129CrossRef Ying GS, Huang J, Maguire MG et al (2013) Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 120:122–129CrossRef
2.
Zurück zum Zitat Ying GS, Kim BJ, Maguire MG et al (2014) Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA ophthalmol 132:915–921CrossRef Ying GS, Kim BJ, Maguire MG et al (2014) Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA ophthalmol 132:915–921CrossRef
3.
Zurück zum Zitat Ying GS, Maguire MG, Daniel E et al (2015) Association of baseline characteristics and early vision response with 2-year vision outcomes in the Comparison of AMD Treatments Trials (CATT). Ophthalmology 122(2523–31):e1 Ying GS, Maguire MG, Daniel E et al (2015) Association of baseline characteristics and early vision response with 2-year vision outcomes in the Comparison of AMD Treatments Trials (CATT). Ophthalmology 122(2523–31):e1
4.
Zurück zum Zitat Willoughby AS, Ying GS, Toth CA et al (2015) Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(1846–53):e5 Willoughby AS, Ying GS, Toth CA et al (2015) Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(1846–53):e5
5.
Zurück zum Zitat Ristau T, Keane PA, Walsh AC et al (2014) Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica 231:37–44CrossRef Ristau T, Keane PA, Walsh AC et al (2014) Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica 231:37–44CrossRef
6.
Zurück zum Zitat Keane PA, Liakopoulos S, Chang KT et al (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115:2206–2214CrossRef Keane PA, Liakopoulos S, Chang KT et al (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115:2206–2214CrossRef
7.
Zurück zum Zitat Spaide RF, Klancnik JM Jr, Cooney MJ (2015) Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA ophthalmol 133:45–50CrossRef Spaide RF, Klancnik JM Jr, Cooney MJ (2015) Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA ophthalmol 133:45–50CrossRef
8.
Zurück zum Zitat Dansingani KK, Tan AC, Gilani F et al (2016) Subretinal hyperreflective material imaged with optical coherence tomography angiography. Am J Ophthalmol 169:235–248CrossRef Dansingani KK, Tan AC, Gilani F et al (2016) Subretinal hyperreflective material imaged with optical coherence tomography angiography. Am J Ophthalmol 169:235–248CrossRef
9.
Zurück zum Zitat Kawashima Y, Hata M, Oishi A et al (2017) Association of vascular versus avascular subretinal hyperreflective material with aflibercept response in age-related macular degeneration. Am J Ophthalmol 181:61–70CrossRef Kawashima Y, Hata M, Oishi A et al (2017) Association of vascular versus avascular subretinal hyperreflective material with aflibercept response in age-related macular degeneration. Am J Ophthalmol 181:61–70CrossRef
10.
Zurück zum Zitat Shah VP, Shah SA, Mrejen S, Freund KB (2014) Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina 34:1281–1288CrossRef Shah VP, Shah SA, Mrejen S, Freund KB (2014) Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina 34:1281–1288CrossRef
11.
Zurück zum Zitat Miere A, Semoun O, Cohen SY et al (2015) Optical coherence tomography angiography features of subretinal fibrosis in age-related macular degeneration. Retina 35:2275–2284CrossRef Miere A, Semoun O, Cohen SY et al (2015) Optical coherence tomography angiography features of subretinal fibrosis in age-related macular degeneration. Retina 35:2275–2284CrossRef
12.
Zurück zum Zitat Ores R, Puche N, Querques G et al (2014) Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol 158:354–361CrossRef Ores R, Puche N, Querques G et al (2014) Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol 158:354–361CrossRef
13.
Zurück zum Zitat Dansingani KK, Freund KB (2015) Optical coherence tomography angiography reveals mature tangled vascular networks in eyes with neovascular age-related macular degeneration showing resistance to geographic atrophy. Ophthalmic Surg Lasers Imaging Retina 46:907–912CrossRef Dansingani KK, Freund KB (2015) Optical coherence tomography angiography reveals mature tangled vascular networks in eyes with neovascular age-related macular degeneration showing resistance to geographic atrophy. Ophthalmic Surg Lasers Imaging Retina 46:907–912CrossRef
Metadaten
Titel
Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography
verfasst von
Maiko Maruyama-Inoue
Shimpei Sato
Shin Yamane
Kazuaki Kadonosono
Publikationsdatum
01.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 11/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-4121-7

Weitere Artikel der Ausgabe 11/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.